HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Are intravenous immunoglobulins useful in severe episodes of autoimmune hemolytic anemia?: Comparative results in 21 episodes from a single centre].

AbstractBACKGROUND AND OBJECTIVE:
To analyze haemolytic episodes in patients with warm antibody autoimmune haemolytic anemia (AIHA) and compare corticosteroids treatment with intravenous immunoglobulins (IVIG) (group A) or without IVIG (group B).
PATIENTS AND METHODS:
Observational study that includes 21 haemolytic episodes occurred in 17 patients (9 males and 12 females), with a median age of 59 years (26-82). In group A, 8 episodes received IGIV + corticosteroids and in group B, 12 episodes received only corticosteroids and one rituximab.
RESULTS:
Hemoglobin (Hb) value at diagnosis was 1.8 g/dl lower (95% confidence interval: 0.6 to 3.1; P = .007) in group A, with a median Hb of 6.3g/dl in this group vs 7.9 g/dl in group B. There were non-significant differences in red blood cells transfusion (50 vs 23%; P > .20) and global increase of Hb values (7.3 vs 5.6; P > .20). Overall hematological responses were similar: 88 vs 92% (P > .20).
CONCLUSIONS:
Hematological response achieved in more severe episodes with the use of IVIG was similar to non-severe episodes treated without IVIG.
AuthorsJuan José Gil-Fernández, Elena Flores Ballester, María González Martínez, Juan Arévalo-Serrano, Ana Teresa Tamayo Martín, Carmen Burgaleta Alonso de Ozalla
JournalMedicina clinica (Med Clin (Barc)) Vol. 141 Issue 5 Pg. 201-4 (Sep 07 2013) ISSN: 1578-8989 [Electronic] Spain
Vernacular TitleInmunoglobulinas intravenosas en los episodios graves de anemia hemolítica autoinmune: resultados comparativos en 21 episodios de un único centro.
PMID22857805 (Publication Type: Comparative Study, English Abstract, Journal Article, Observational Study)
CopyrightCopyright © 2012 Elsevier España, S.L. All rights reserved.
Chemical References
  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal, Murine-Derived
  • Hemoglobins
  • Immunoglobulins, Intravenous
  • Rituximab
Topics
  • Adrenal Cortex Hormones (administration & dosage, therapeutic use)
  • Adult
  • Aged
  • Aged, 80 and over
  • Anemia, Hemolytic, Autoimmune (blood, drug therapy, therapy)
  • Antibodies, Monoclonal, Murine-Derived (administration & dosage, therapeutic use)
  • Blood Cell Count
  • Blood Transfusion
  • Combined Modality Therapy
  • Female
  • Hemoglobins (analysis)
  • Hemolysis
  • Humans
  • Immunoglobulins, Intravenous (administration & dosage, therapeutic use)
  • Male
  • Middle Aged
  • Rituximab
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: